<DOC>
	<DOC>NCT01938027</DOC>
	<brief_summary>The purpose of this study is evaluation of the safety and the efficacy of transanal total mesorectal excision.</brief_summary>
	<brief_title>The Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision</brief_title>
	<detailed_description>Subjects will have their rectal cancer removed using a technique combining surgery through the anus and standard laparoscopy. Transanal visualization will be using endoscopy. At the end of the procedure, the rectum will be removed though the anus or ileostomy formation site, the bowel will be re-connected to the anus, and a temporary diverting stoma will be created, which is standard of care following surgery for this type of cancer.</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>age: 2080 years biopsyproven adenocarcinoma of the rectum clinical staging, (T1 or T2 or T3) with N0M0 Rectal cancer located 412 cm from the anal verge ECOG performance status 2 or less Synchronous colon cancer or other malignancy Obstructing rectal cancer Pregnant or breastfeeding Receiving any other study agents Fecal incontinence History of prior colorectal cancer or inflammatory bowel disease BMI &gt; 30 T3 rectal cancer not treated preoperatively with fullcourse chemoradiation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Rectal Neoplasms</keyword>
	<keyword>Colorectal Neoplasms</keyword>
	<keyword>transanal surgery</keyword>
</DOC>